http://stroke.ahajournals.org/content/45/2/359.extract?etoc
- Emanuela Keller, MD;
- Kyra J. Becker, MD
+ Author Affiliations
- Correspondence to Kyra J. Becker, MD, Box 359775 HMC, 325 9th Ave, Seattle, WA 98104-2499. E-mail kjb@uw.edu
Introduction
Of the many publications in this field, the ones discussed hereunder seem to be most relevant for clinical practice.
Ischemic Stroke
Intravenous thrombolysis with tissue
plasminogen activator (tPA) is the only therapy proven to improve
outcome in ischemic
stroke. Studies of intravenous thrombolysis
show that response to therapy is time-dependent; the sooner the patients
receive
tPA, the better the chance of good outcome.1
The required brain imaging before tPA administration delays the
initiation of therapy because it necessitates patient transport.
In the Pre-Hospital Acute Neurological
Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) pilot
study, Weber
et al2
attempt to speed up stroke treatment by administering tPA before
hospital arrival. When patients with presumed stroke contacted
the emergency medical system, a stroke
emergency mobile unit equipped with a CT scanner was dispatched. Brain
imaging was
performed at the scene, enabling tPA
administration in the stroke emergency mobile unit. For patients in
stroke emergency
mobile unit, the median time between
emergency call and initiation of tPA was 58 minutes (5–63); this time
was 92 minutes
(79–112) in a group of historic controls. The
PHANTOM-S study was a nonrandomized study performed in urban Germany. A
randomized
controlled study performed in a more rural
region of Germany showed a similar relative decrease in the time to tPA
treatment
among patients treated in a CT-equipped
mobile stroke unit compared with those treated in the emergency room.3 These studies show that CT-equipped mobile stroke units decrease the time to tPA administration, which could …
No comments:
Post a Comment